Clinical Trials Browser

Pilonidal Sinus, Recurrence

NCT07400809 2026-02-17

Retro-COSMOS

Recruiting

350 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT07290972 2026-02-04

NCG-Compliance

Recruiting

618 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Patient Compliance, Recurrence

NCT07361666 2026-01-23

HFUS-CLEAR

Not yet recruiting

400 enrolled

Dermatologic

Margins of Excision, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT06325410 2024-03-22

Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience

Completed

200 enrolled

Gastrointestinal

Neoplasms, Recurrence, Colorectal Neoplasms

NCT06088719 2023-10-18

Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

Unknown

300 enrolled

Breast

Breast Neoplasms, Recurrence

NCT04021212 2022-05-11

Pituitary Adenoma and Serum Lipid

Unknown

1,000 enrolled

Endocrine

Pituitary Diseases, Pituitary Neoplasms, Recurrence

NCT04699162 2021-01-14

HGMHRAEI/ALL

Completed

56 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02648789 2018-08-09

Validation of DNA Methylation Biomarkers for Oral Cancer Detection

Completed

46 enrolled

Head & Neck

Mouth Neoplasms, Recurrence

NCT00815555 2008-12-30

CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients

Unknown

500 enrolled

Breast

Breast Neoplasms, Recurrence

Clinical Trials

PiloPedia

Retro-COSMOS

NCG-Compliance

HFUS-CLEAR

Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience

Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

Pituitary Adenoma and Serum Lipid

HGMHRAEI/ALL

Validation of DNA Methylation Biomarkers for Oral Cancer Detection

CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients